FORMYCON
Formycon GmbH is more than a regular CRO that provides formulation and analytical services to the biopharmaceutical industry. The complete analytical development chain – starting from protein characterization and comparability studies up to GMP Quality Control and stability testing of clinical study and market medication. The Formulation one-stop shop – Formycon covers pre-formulation, development of systemic and local, liquid, freeze-dried and sustained release drug product formulations, supply of pre-clinical studies and development of the manufacturing process.
FORMYCON
Industry:
Biopharma
Founded:
1999-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.formycon.com
Total Employee:
101+
Status:
Active
Total Funding:
290 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Current Employees Featured
Stock Details
Investors List
Bavarian Research Foundation
Bavarian Research Foundation investment in Grant - Formycon
Official Site Inspections
http://www.formycon.com Semrush global rank: 2.71 M Semrush visits lastest month: 6.08 K
- Host name: 193.254.184.45
- IP address: 193.254.184.45
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Formycon"
Home - Formycon AG
8 rows Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2024 ein und gibt Teilnahme an internationalen Investorenkonferenzen im 2. Quartal 2025 bekannt 24. März 2025. …See details»
Governance (ESG) - Formycon AG
Formycon has succeeded in recruiting and integrating outstanding talents into the organization. In addition, with our newly developed employer branding concept, we not only want to be …See details»
Home - Formycon AG
8 rows Formycon’s employees are the foundation of our success. We …See details»
About Us - Formycon AG
Through the biosimilars which we develop, Formycon strives to make a significant contribution to enabling the broadest possible patient access to these vital drugs – and bears social responsibility in this way. Discover Formycon. Vision & …See details»
Formycon - Crunchbase Company Profile & Funding
Formycon GmbH is more than a regular CRO that provides formulation and analytical services to the biopharmaceutical industry. The complete analytical …See details»
Formycon Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Formycon has 5 employees at their 1 location and €77.7 m in annual revenue in FY 2023. See insights on Formycon including office locations, competitors, revenue, …See details»
Org Chart Formycon - The Official Board
Organizational Chart of Formycon. Formycon www.formycon.com. has 10 executives +49 898 6466 7100; Add an executive. Formycon News . Anything missing? We search for you. Print or …See details»
Formycon AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Formycon AG of Planegg, Bayern. Get the latest business insights from Dun & Bradstreet. Formycon AG. …See details»
Formycon - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Jan 29, 2024: Post-IPO Equity - Formycon . 1: …See details»
Formycon - Contacts, Employees, Board Members, Advisors
Formycon provides formulation and analytical services to the biopharmaceutical industry.See details»
Formycon AG
Formycon has an existing network of preferred and trustred recruitment agencies in place. Formycon solely accepts candidate profiles via the job portal on the Formycon website, …See details»
Formycon AG (LON:0W4N) Company Profile & Description - Stock …
Mar 18, 2025 Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland. It provides FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug …See details»
Formycon reports on a successful financial year 20…
13 hours ago EQS-News: Formycon AG / Key word(s): Annual Report/Annual Results Formycon reports on a successful financial year 2024 with strong operational progress and continuous …See details»
Formycon 2025 Company Profile: Stock Performance & Earnings
What is Formycon’s annual earnings per share (EPS)? Formycon’s EPS for 12 months was $4.40. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re …See details»
Formycon - Overview, News & Similar companies | ZoomInfo.com
Who is Formycon. Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in …See details»
Formycon - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 26, 2025 Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®WebDisclosure • Nov …See details»
About Formycon - Formycon AG
Formycon is an established, successful, and independent pure-play biosimilar company specializing in the development of cost-effective follow-on products for complex …See details»
History - Formycon AG
With the company’s founding roots in Scil Group, an offshoot of Boehringer Mannheim, Formycon’s organization and biopharmaceutical development expertise date back much …See details»
Formycon burdened by write-downs - aims to become sustainably ...
9 hours ago Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in …See details»
Formycon AG (Formycon AG) - 药物管线_专利_临床试验_投融营 …
了解Formycon AG (Formycon AG)公司的药物管线，治疗领域，技术平台，以及它的13项临床试验, 63篇新闻和2篇文献，疾病领域:内分泌与代谢疾病，肿瘤，免疫系统疾病，感染，技术平台:生 …See details»